跳至内容 跳至页脚
Factor ix: Benefits, Reviews, Info, Side Effects!
Rx 详细信息
Factor ix
Antihemophilic factor, coagulation factor IX, Christmas factor, FIX
Coagulation factor IX
药物
补充剂
仅限处方
可用的
blood clotting, treatment of hemophilia B, prevention of bleeding episodes, perioperative management in hemophilia B patients, improvement in quality of life for hemophilia B patients
Allergic Reactions, Back Pain, Chills, Dizziness, Fatigue, Fever, Flushing, Headache, Itching, Joint Pain, Muscle Pain, Nausea, Pain At The Injection Site, Rash, Vomiting
Factor IX is a clotting factor used in the treatment of hemophilia B, a genetic bleeding disorder. The dosage of Factor IX can vary significantly depending on several factors, including the severity of the deficiency, the patient’s weight, the type of product used (recombinant or plasma-derived), and the specific clinical situation (e.g., routine prophylaxis, treatment of bleeding episodes, or surgery). Typically, the dosage is calculated based on the patient’s weight and the desired increase in Factor IX activity levels. A common formula used is: [ text{Dose (IU)} = text{Body Weight (kg)} times text{Desired Increase in Factor IX Activity (%)} times text{Factor} ] The factor is often around 1.0 for recombinant products, meaning that 1 IU/kg of Factor IX typically raises the plasma level by about 1%. For example, if a patient weighing 70 kg needs to increase their Factor IX level by 30%, the calculation would be: [ 70 , text{kg} times 30 , % times 1.0 = 2100 , text{IU} ] It’s important to note that these are general guidelines, and the exact dosage should always be determined by a healthcare professional based on individual patient needs and response to treatment.
Hemophilia b
Factor IX has a generally safe safety profile.
未报告任何相互作用
$100 – $500
$1000-$2,000 per vial.

摘要

Factor ix

Factor IX, also known as Christmas factor, is a crucial protein in the blood clotting process. This protein is responsible for activating other clotting factors to form a blood clot and stop bleeding. Factor IX deficiency, also known as hemophilia B, can result in prolonged bleeding and difficulty in clot formation.

Treatment for Factor IX deficiency often involves the administration of Factor IX concentrate. This concentrate is derived from human plasma or produced through recombinant DNA technology. By replacing the missing Factor IX in the blood, clot formation can be improved, and bleeding episodes can be controlled.

Factor IX concentrate is typically administered through intravenous infusion and dosing is based on the severity of the deficiency and the patient’s weight. Regular infusions may be required to maintain adequate levels of Factor IX in the blood and prevent bleeding episodes.

It is important for patients with Factor IX deficiency to work closely with their healthcare provider to monitor their condition and adjust treatment as needed. Regular blood tests may be necessary to ensure that Factor IX levels are within the desired range.

While Factor IX concentrate can be highly effective in managing Factor IX deficiency, it is important to be aware of potential side effects, such as allergic reactions or the development of inhibitors. Patients should always discuss any concerns or questions with their healthcare provider.

Overall, Factor IX concentrate plays a vital role in the treatment of Factor IX deficiency and can significantly improve the quality of life for patients with this condition. By working closely with a healthcare provider and following a personalized treatment plan, individuals with Factor IX deficiency can effectively manage their condition and reduce the risk of bleeding episodes.

RxDb 法律免责声明

RxDB.net 上提供的信息仅供参考,并非旨在取代专业的医疗建议、诊断或治疗。如果您对健康、药物或医疗状况有任何疑问或担忧,请务必咨询合格的医疗保健专业人员,例如医生或药剂师。依赖本网站提供的任何信息的风险完全由您自行承担。RxDB.net 不提供医疗或制药服务,对基于此处包含的信息做出的任何决定概不负责。

页面最后更新时间

0
希望看到您的想法,请您发表评论
zh_CNZH